SCHEMBL5754413

SCHEMBL5754413

COCCc1nc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2)nc1C(=O)OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 2/20 0.50
ALDH1A1 P00352 4/20 0.47
KDM4E B2RXH2 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
PKM P14618 1/20 0.47
MAPT P10636 3/20 0.43
NPC1 O15118 1/20 0.43
NFKB1 P19838 1/20 0.43
RAB9A P51151 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
LMNA P02545 1/20 0.42
DHODH Q02127 1/20 0.41
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
HPGD P15428 2/20 0.40
HSD17B10 Q99714 2/20 0.40
S1PR4 O95977 1/20 0.40
CA12 O43570 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4680862 0.88 CNR1 (0.59) CNR1ALDH1A1KDM4ESMN1; SMN2L3MBTL1
SCHEMBL4680181 0.87 CNR1 (0.52) CNR1ALDH1A1KDM4ESMN1; SMN2L3MBTL1
SCHEMBL4676300 0.79 SMN1; SMN2 (0.52) CNR1ALDH1A1KDM4ESMN1; SMN2L3MBTL1
SCHEMBL4783347 0.78 CNR1 (0.48) CNR1ALDH1A1KDM4ESMN1; SMN2L3MBTL1
SCHEMBL4680964 0.76 CNR1 (0.52) CNR1ALDH1A1KDM4ESMN1; SMN2L3MBTL1
SCHEMBL4681335 0.76 CNR1 (0.51) CNR1ALDH1A1KDM4ESMN1; SMN2L3MBTL1
SCHEMBL4677242 0.76 CNR1 (0.46) CNR1ALDH1A1KDM4ESMN1; SMN2L3MBTL1
SCHEMBL4679820 0.76 TARBP2 (0.55) KDM4EMAPTNPC1RAB9ADHODH
SCHEMBL4676636 0.75 CNR1 (0.50) CNR1ALDH1A1KDM4EDHODHHPGD
SCHEMBL4681021 0.75 CNR1 (0.57) CNR1ALDH1A1KDM4ESMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1638953-A1 3-SUBSTITUTED 5,6-DIARYL-PYRAZINE-2-CARBOXAMIDE AND -2-SULFONAMIDE DERIVATIVES AS CB1 MODULATORS AstraZeneca AB (SE) 2006-03-29 EP disclosed
WO-2004111034-A1 3-SUBSTITUTED 5,6-DIARYL-PYRAZINE-2-CARBOXAMIDE AND -2-SULFONAMIDE DERIVATIVES AS CB1 MODULATORS ASTRAZENECA AB (SE) 2004-12-23 WO disclosed